4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000905718-17-000749
Director sold 50,477 shares at an average $17.81 ($899,216)
From the SEC's structured data for this filing
Trades in this filing
EMSTER KURT VON · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-08-03 | Sale : show line 1 in the form | −47,409 | $17.77 | $842,458 | 2,229,413 | I |
| 2017-08-04 | Sale : show line 2 in the form | −3,068 | $18.50 | $56,758 | 2,226,345 | I |
| Open-market sales · 50,477 sh · avg $17.81 · $899,216 | ||||||
Loading xslF345X03/vonemster_fm4aug32017.xml…